Snapshot from Sep 18, 2026 at 07:00 UTC. For live data and tracking: View Live
Business earnings report

Medtronic Q1 Beat, Raises FY27 Guidance

Analysis based on 6 articles · First reported Sep 01, 2026 · Last updated Sep 01, 2026

Sentiment
60
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Medtronic's strong Q1 results and raised guidance signal robust demand for its medical devices, likely boosting investor confidence in the company and the broader medical device sector. The stock rose in pre-market trading, reflecting positive market reaction to the earnings beat and strategic investments in surgical robotics and structural heart technologies.

Medical Devices Healthcare

Medtronic reported fiscal Q1 2027 results that beat expectations, with net income of $1.47 billion ($1.14 per share) versus $1.04 billion ($0.81 per share) a year ago. Adjusted EPS was $1.45, up from $1.26. Net sales grew 13.7% to $9.76 billion, aided by an extra fiscal week that contributed about $570 million to organic growth. All four business segments posted double-digit growth: Cardiovascular up 19.5%, Neuroscience up 10.3%, Medical Surgical up 10.0%, and Diabetes up 16.9%. Operating margin improved 130 basis points to 18.1%. The company raised its FY2027 adjusted EPS guidance to $5.94-$6.00 and organic revenue growth to 7.25%-7.75%, up from prior $5.90-$6.00 and 6.75%-7.25%. CFO Thierry Pieton attributed the beat to strong operating performance and disciplined financial management. Additionally, Medtronic announced a strategic partnership with Cornerstone Robotics, investing approximately $700 million for distribution rights to its Sentire surgical system in select markets, and a strategic investment of up to $80 million in Pi-Cardia Ltd., with an option to acquire Pi-Cardia for up to $210 million plus earn-outs upon achieving milestones. In pre-market trading, MDT rose about 3-5% on the New York Stock Exchange.

90 Medtronic reported profit
85 Medtronic raised FY27 guidance
65 Medtronic invested in Pi-Cardia Pi-Cardia Ltd.
stock
Medtronic is the central entity, reporting strong Q1 results, raising FY27 guidance, and announcing strategic investments. The positive earnings and raised outlook are likely to boost its stock price and investor sentiment.
Importance 100.0 Sentiment 70.0
priv
Cornerstone Robotics receives a $700 million investment from Medtronic, gaining distribution rights for its Sentire surgical system in select markets. This partnership validates its technology and provides significant capital and market access.
Importance 60.0 Sentiment 80.0
priv
Pi-Cardia receives up to $80 million investment from Medtronic, with an option for acquisition up to $210 million plus earn-outs. This provides funding and potential exit opportunity, enhancing its value.
Importance 50.0 Sentiment 75.0
per
As CFO, Thierry Pieton is the spokesperson for the results and guidance, reinforcing confidence in Medtronic's financial management.
Importance 30.0 Sentiment 50.0
exch
The New York Stock Exchange is the exchange where Medtronic's stock trades, and the positive earnings led to a pre-market stock price increase, reflecting market activity.
Importance 20.0 Sentiment 40.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.